Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
Pro-angiogenic activity of isofuran
Jingxia Zhang1, Xiangjiang Wang1, Zhiping Lin1
1Key Laboratory of Translational Tumor Medicine in Fujian Province, School of Basic Medical Science Putian University, Putian, Fujian, China.
Isofurans (IsoFs), novel lipid peroxidation products, promote blood vessel formation (angiogenesis). Researchers found IsoF enhances endothelial cell proliferation, migration, and vascularization, suggesting therapeutic potential.
Area of Science:
- Biochemistry
- Cell Biology
- Physiology
Background:
- Isofurans (IsoFs) are newly identified products of lipid peroxidation.
- Understanding the biological functions of IsoFs, particularly in vascular biology, is crucial.
Purpose of the Study:
- To investigate the angiogenic properties of Isofurans (IsoFs).
- To elucidate the molecular mechanisms underlying IsoF-induced angiogenesis.
Main Methods:
- MTT assay for cell viability in rat brain endothelial cells (RBECs).
- TUNEL assay to assess apoptosis.
- Rat aortic ring assay and chick choroid explant assay for vascularization.
- RT-PCR to analyze gene expression.
- Measurement of intracellular calcium release and ERK1/2 phosphorylation.
Main Results:
- 1 µm IsoF exhibited maximal bioactivity in RBECs.
- IsoF significantly promoted cell proliferation and migration while reducing apoptosis.
- IsoF enhanced vascularization in aortic and choroid explants.
- IsoF upregulated TNFα, Tie2, and VEGF-A expression, with involvement of calcium release and ERK1/2 signaling.
Conclusions:
- Isofurans possess significant pro-angiogenic activity.
- The pro-angiogenic effects of IsoF are mediated by the upregulation of TNFα, Tie2, and VEGF-A.
- Calcium release and ERK1/2 phosphorylation are likely key signaling pathways in IsoF-induced angiogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

